LIGAND PHARMACEUTICALS INCORPORATED Net Cash Provided by (Used in) Financing Activities, Continuing Operations
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of -$840.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q/A filed 2012-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2012-11-14
- LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) financing activities, continuing operations for the quarter ending 2012-03-31 was -$840.00K, a 103.37% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) financing activities, continuing operations for the quarter ending 2011-03-31 was $24.95M.
- LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) financing activities, continuing operations for fiscal 2011 was $30.00M.
- LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) financing activities, continuing operations for fiscal 2010 was -$159.00K.
- LIGAND PHARMACEUTICALS INCORPORATED net cash provided by (used in) financing activities, continuing operations for fiscal 2009 was -$3.69M.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|
| 2012-03-31 | -$840.00K 10-Q/A · filed 2012-11-14 | |
| 2011-12-31 | $30.00M 10-K/A · filed 2012-11-14 | |
| 2011-03-31 | $24.95M 10-Q/A · filed 2012-11-14 | |
| 2010-12-31 | -$159.00K 10-K/A · filed 2012-11-14 | |
| 2009-12-31 | -$3.69M 10-K/A · filed 2012-11-14 |